Nagla Fawzy Abdel Karim

Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer

Nicholas J. Vogelzang, Tomasz M. Beer, Winald R. Gerritsen et al. · JAMA Oncology · 2022 · 90 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

SWOG S1929: Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer (ES-SCLC).

Nagla Fawzy Abdel Karim, Jieling Miao, Karen L. Reckamp et al. · Journal of Clinical Oncology · 2023 · 34 citations

Medicine, Oncology, Pharmacology +14

Safety results of NRG-LU004: Phase I trial of accelerated or conventionally fractionated radiotherapy combined with durvalumab in PD-L1–high locally advanced non-small cell lung cancer.

Steven H. Lin, Stephanie L. Pugh, Anne S. Tsao et al. · Journal of Clinical Oncology · 2022 · 17 citations

Medicine, Oncology, Radiation Oncology +17

DNA damage response and repair (DDR) gene mutations and correlation with tumor mutation burden (TMB) in non-small cell lung cancer (NSCLC).

Hirva Mamdani, Jerry Yongqiang Chen, Seongho Kim et al. · Journal of Clinical Oncology · 2019 · 13 citations

Life Sciences, Molecular Biology, Oncology +17

Impact of tricyclic antidepressants, selective serotonin reuptake inhibitors, and other antidepressants on overall survival of patients with advanced lung cancer from 2004 to 2014: University of Cincinnati experience

Nagla Fawzy Abdel Karim, Rammey Hassan, Nabeela Iffat Siddiqi et al. · Journal of International Medical Research · 2019 · 11 citations · Full text

Medicine, Oncology, Pharmacotherapy +15